Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors - PubMed
3 hours ago
- #dark chocolate
- #cardiovascular health
- #liver disease
- Cardiovascular diseases and metabolic dysfunction-associated steatotic liver disease (MASLD) share common pathophysiological pathways including oxidative stress, inflammation, hyperglycemia, obesity, dyslipidemia, and hypertension.
- Dark chocolate, rich in cocoa flavanols like epicatechin and catechin, has antioxidant and anti-inflammatory properties.
- Clinical studies suggest chocolate improves nitric oxide bioavailability, flow-mediated dilation, lipid profiles (increased HDL-c, reduced LDL-c and triglycerides), and reduces hepatocyte apoptosis.
- Evidence supports moderate dark chocolate consumption as a potential adjunct strategy for cardiometabolic and hepatic health, though study limitations exist.
- Further large-scale, long-term trials are needed to confirm benefits and standardize cocoa flavanol dosage and formulation.